From November 19 to November 20, 2022, the "2022 Institute of Cancer Research Symposium, SZBL" was successfully held at the Gaoke Innovation Center. This symposium is a combination of on-site participation and online live streaming, inviting experts and scholars in the field of tumor biology from all over China to gather at SZBL to share this pioneering and innovative feast of ideas. During the symposium, the total number of participants on site was about 170, and the number of online live viewers exceeded 10,000, making the meeting a complete success.

Wu Yun-Dong, the Chinese Academy of Sciences academician and Executive Vice Director of SZBL attended the opening ceremony and delivered a speech. Shen Xuetong, the Vice Director of the Institute of Cancer Research and Senior Principal Researcher, introduced the recent development of the Institute.

The symposium brought together top experts and scholars in the field of oncobiology to conduct in-depth discussions on two main themes: oncobiology and translational research. Participants exchanged the latest research results in basic theory and clinical research in oncobiology, which will help to jointly promote the translational application of tumor research and open up the innovative field of diagnosis and treatment in China.

Professor Zhang Zemin and Professor Lei Xiaoguang from Peking University, Professor Ye Lilin from Army Medical University, and Professor Fan Xiaohu from Xi'an Jiaotong University were invited to deliver keynote presentations. More than 20 experts were invited to give special presentations. They come from Peking University Health Science Center, Southern University of Science and Technology, Shanghai Jiao Tong University School of Medicine, Shenzhen University Health Science Center, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, the Seventh Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, Nanfang Hospital of Southern Medical University, Shenzhen Hospital of Southern Medical University, and Redhill Capital. The experts introduced their research areas and brought reports on the latest research progress, and the audience actively asked questions and had a lively discussion.

The symposium aims to strengthen the cooperation between the SZBL and its colleagues in oncobiology in the Greater Bay Area (GBA) and even nationwide. It will also continue to promote cooperation with scientific and technological capital, providing a new platform for tumor research and translation in the GBA and even nationwide and helping Shenzhen become the core engine of a comprehensive national science center in the GBA.